搜索临床试验以:Fruquintinib 和 Camrelizumab 的组合
总计147107个结果
-
The First Affiliated Hospital with Nanjing Medical...招聘中
-
Zealand University HospitalUniversity of Copenhagen; Steno Diabetes Center Copenhagen; Holbaek Sygehus招聘中
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University招聘中
-
Chinese PLA General HospitalHutchison Medipharma Limited招聘中
-
Peking University People's HospitalJiangsu HengRui Medicine Co., Ltd.; Peking University Shougang Hospital撤销
-
Peking Union Medical College Hospital完全的
-
Sun Yat-sen UniversityJiangsu Hengrui Pharmaceutical Co., Ltd.尚未招聘
-
Huazhong University of Science and Technology主动,不招人
-
The First Affiliated Hospital of Zhengzhou University招聘中
-
Sun Yat-sen UniversityJiangsu HengRui Medicine Co., Ltd.招聘中
-
Henan Provincial People's Hospital尚未招聘
-
Huashan HospitalJiangsu HengRui Medicine Co., Ltd.; Shanghai Sunstem Biotechnology Co., Ltd.招聘中
-
Tianjin Medical University Cancer Institute and...招聘中
-
Immunitas Therapeutics招聘中滤泡性淋巴瘤 | 大肠癌 | 霍奇金淋巴瘤 | 食道癌 | 小肠癌 | 伯基特淋巴瘤 | 非小细胞肺癌 | 三阴性乳腺癌 | 弥漫性大 B 细胞淋巴瘤 | 头颈部鳞状细胞癌 | 激素受体阳性乳腺癌 | 皮肤鳞状细胞癌美国
-
Bronx VA Medical Center完全的
-
Xingchen PengJiangsu HengRui Medicine Co., Ltd.未知
-
The First Affiliated Hospital of Zhengzhou University招聘中
-
Fudan University主动,不招人
-
Jiangsu HengRui Medicine Co., Ltd.主动,不招人根治性切除或消融后复发风险高的肝细胞癌 (HCC) 患者的辅助治疗中国
-
Jiangsu HengRui Medicine Co., Ltd.招聘中
-
Tianjin Medical University Cancer Institute and...尚未招聘
-
Sun Yat-sen UniversityJiangsu HengRui Medicine Co., Ltd.招聘中